Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibody Persistence and Immune Memory Against Hepatitis B in 11-12 Year Olds
NCT01138098Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of pertussis filamentous haemagglutinin in hepatitis B (HBV), sponsored by GSK. Started Jun 2010; status: completed.
02
Drugs
pertussis filamentous haemagglutinin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01138098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138098.